Sarepta Therapeutics Inc (SRPT)
132.54
-3.57
(-2.62%)
USD |
NASDAQ |
May 08, 16:00
132.54
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Cash and Short Term Investments (Quarterly): 1.391B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.391B |
| December 31, 2023 | 1.676B |
| September 30, 2023 | 1.734B |
| June 30, 2023 | 1.861B |
| March 31, 2023 | 1.882B |
| December 31, 2022 | 1.989B |
| September 30, 2022 | 2.072B |
| June 30, 2022 | 1.928B |
| March 31, 2022 | 2.013B |
| December 31, 2021 | 2.116B |
| September 30, 2021 | 1.599B |
| June 30, 2021 | 1.727B |
| March 31, 2021 | 1.738B |
| December 31, 2020 | 1.939B |
| September 30, 2020 | 1.816B |
| June 30, 2020 | 2.061B |
| March 31, 2020 | 2.171B |
| December 31, 2019 | 1.125B |
| September 30, 2019 | 1.049B |
| June 30, 2019 | 1.103B |
| March 31, 2019 | 1.344B |
| December 31, 2018 | 1.174B |
| September 30, 2018 | 792.86M |
| June 30, 2018 | 949.14M |
| March 31, 2018 | 1.049B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.079B |
| September 30, 2017 | 617.63M |
| June 30, 2017 | 300.95M |
| March 31, 2017 | 390.31M |
| December 31, 2016 | 317.84M |
| September 30, 2016 | 395.14M |
| June 30, 2016 | 123.22M |
| March 31, 2016 | 129.16M |
| December 31, 2015 | 192.49M |
| September 30, 2015 | 99.91M |
| June 30, 2015 | 156.89M |
| March 31, 2015 | 166.22M |
| December 31, 2014 | 210.34M |
| September 30, 2014 | 236.02M |
| June 30, 2014 | 279.54M |
| March 31, 2014 | 225.19M |
| December 31, 2013 | 256.96M |
| September 30, 2013 | 273.64M |
| June 30, 2013 | 156.18M |
| March 31, 2013 | 167.92M |
| December 31, 2012 | 187.66M |
| September 30, 2012 | 37.99M |
| June 30, 2012 | 24.49M |
| March 31, 2012 | 30.57M |
| December 31, 2011 | 39.90M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.049B
Minimum
Sep 2019
2.171B
Maximum
Mar 2020
1.750B
Average
1.838B
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| PTC Therapeutics Inc | 884.81M |
| Amgen Inc | 9.708B |
| Regenxbio Inc | 275.26M |
| Apellis Pharmaceuticals Inc | 351.18M |
| Alnylam Pharmaceuticals Inc | 2.371B |